The Prevalence of Coagulopathy and Associated Factors Among Adult Type II Diabetes Mellitus Patients Attending the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

Figures & data

Figure 1 Algorithm of mixing study for the determination of factor deficiency and pathological factor inhibitors.

Table 1 Socio-Demographic Characteristics of Adult T2DM Patients Attending the UoGCSH Chronic Illness Clinic, Northwest Ethiopia, 2021

Sociodemographic Characteristics		Frequency	Percentage
Gender	Male	171	47.9%
	Female	186	52.1%
Age	18–39	34	9.5%
	40–64	257	72.0%
	>65	66	18.5%
Place of residence	Urban	288	80.7%
	Rural	69	19.3%
Educational status	Unable to read and write	97	27.2%
	Elementary	110	30.8%
	High school	90	25.2%
	College and above	60	16.8%
Occupation	Housewife	89	24.9%
	Office work	66	18.5%
	Merchant	61	17.1%
	Farmer	53	14.8%
	In retirement	45	12.6%
	Private	43	12.04%

Table 2 Clinical and Behavioral Characteristics of Adult T2DM Patients Attending the UoGCSH Chronic Illness Clinic, Northwest Ethiopia, 2021

Clinical and Behavioral Characteristics		Frequency	Percentage
Duration of DM in years	<6	235	65.8%
	≥6	122	34.2%
Antidiabetic drug use status	Yes	356	99.7%
	No	1	0.3%
Duration of antidiabetic drug use in years	<6	236	66.1%
	≥6	121	33.9%
Traditional medicine use	Yes	27	7.6%
	No	330	92.4%
Oral contraceptive use (n=186)	Yes	7	3.8%
	No	179	96.2%
Doing regular physical exercise	Yes	150	42.0%
	No	207	58.0%
Cigarette smoking	Yes	5	1.4%
	No	352	98.6%
History of chronic illness	Yes	156	43.7%
	No	201	56.3%
BMI	Underweight	12	3.4%
	Normal	198	55.5%
	Overweight	147	41.2%
Blood pressure	Hypertensive	216	60.5%
	Normotensive	141	39.5%
Anemia	Anemic	31	8.7%
	Non-anemic	326	91.3%

Figure 2 The types of coagulopathy identified among T2DM patients.

Table 3 Factors Associated with Hypercoagulation Among Adult T2DM Patients

Characteristics	Category	Hypercoagulation		COR(95% CI)	P-value	AOR(95% CI)	P-value
		Yes n(%)	No n(%)
Gender	Male	19 (11.1%)	152 (88.9%)	1	0.018		0.023
	Female	38 (20.4%)	148 (79.6%)	0.49 (0.27–0.88)		2.06 (1.11–3.85)
Age	18–39	7 (20.6%)	27 (79.4%)	1
	40–64	39 (15.2%)	218 (84.8%)	1.30 (0.45–3.72)	0.629
	> 65	11 (16.7%)	55 (83.3%)	0.89 (0.43–1.86)	0.765
Residency	Urban	46 (16.0%)	242 (84.0%)	1.00 (0.49–2.05)	0.995
	Rural	11 (15.9%)	58 (84.1%)	1
Educational status	Unable to read and write	18 (18.6%)	79 (81.4%)	1.02 (0.44–2.33)	0.972	0.75 (0.31–1.84)	0.530
	Elementary	21 (19.1%)	89 (80.9%)	1.05 (0.47–2.36)	0.904	0.85 (0.37–1.96)	0.698
	High school	7 (7.8%)	83 (92.2%)	0.38 (0.14–1.03)	0.058	0.29 (0.10–0.83)	0.021
	College and above	11 (18.3)	49 (81.7%)	1
Physical exercise	Yes	20 (13.3%)	130 (86.7%)	1	0.249		0.430
	No	37 (17.9%)	170 (82.1%)	1.42 (0.78–2.55)		0.77 (0.41–1.46)
History of other chronic illness	Yes	25 (16.0%)	131 (84.0%)	0.99 (0.56–1.76)	0.979
	No	32 (15.9%)	169 (84.1%)	1
Duration of DM	<6	41 (17.4%)	194 (82.6%)	1	0.291
	≥6	16 (13.1%)	106 (86.9%)	1.40 (0.75–2.61)
Duration of drug use	<6	41 (17.4%)	195 (82.6%)	1	0.312
	≥6	16 (13.2%)	105 (86.8%)	1.38 (0.74–2.58)
Blood pressure	Hypertensive	37 (17.1%)	179 (82.9%)	0.80 (0.44–1.44)	0.458
	Normotensive	20 (14.2%)	121 (85.8%)	1
BMI	Abnormal	33 (20.8%)	126 (79.2%)	0.53 (0.30–0.94)	0.028	1.94 (1.08–3.50)	0.027
	Normal	24 (12.1%)	174 (87.9%)	1